Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 11753407 Compounds for treating spinal muscular atrophy
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
Date Filed
October 5, 2020
Date of Patent
September 12, 2023
Patent Application Number
17062853
Patent Citations
US Patent 7569337 Coumarines useful as biomarkers
US Patent 7897792 Coumarin derivative having antitumor activity
US Patent 8337941 Fluorescent substrates for monoamine transporters as optical false neurotransmitters
US Patent 8633019 Methods for treating spinal muscular atrophy
US Patent 9586955 Compounds for treating spinal muscular atrophy
US Patent 9617268 Compounds for treating spinal muscular atrophy
US Patent 9969754 Compounds for treating spinal muscular atrophy
US Patent 9879007 Compounds for treating spinal muscular atrophy
US Patent 10208067 Compounds for treating spinal muscular atrophy
US Patent 7326711 Pyridino[1,2-a]pyrimidin-4-one compounds as anticancer agents
•••
Patent Inventor Names
Gary Mitchell Karp
Anthony A. Yurpoff
Emmanuel Pinard
Amal Dakka
Luke Green
Tianle Yang
Hasane Ratni
Marla L. Weetall
Nikolai Naryshkin
Matthew G. Woll
•••
Patent Jurisdiction
United States Patent and Trademark Office
Patent Number
11753407
Patent Primary Examiner
Jeffrey H Murray
CPC Code
A61K 31/519
C07D 487/04
Find more entities like US Patent 11753407 Compounds for treating spinal muscular atrophy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE